These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 19258426)
1. A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits". Kang MI; Henrich CJ; Bokesch HR; Gustafson KR; McMahon JB; Baker AR; Young MR; Colburn NH Mol Cancer Ther; 2009 Mar; 8(3):571-81. PubMed ID: 19258426 [TBL] [Abstract][Full Text] [Related]
2. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets. Lee JC; Kundu JK; Hwang DM; Na HK; Surh YJ Carcinogenesis; 2007 Jul; 28(7):1491-8. PubMed ID: 17372274 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Li JJ; Westergaard C; Ghosh P; Colburn NH Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030 [TBL] [Abstract][Full Text] [Related]
4. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK; Wan CK; Shen XL; Yang M; Fong WF Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. Feng R; Lu Y; Bowman LL; Qian Y; Castranova V; Ding M J Biol Chem; 2005 Jul; 280(30):27888-95. PubMed ID: 15944151 [TBL] [Abstract][Full Text] [Related]
6. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation. Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. Manna SK; Mukhopadhyay A; Aggarwal BB J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.). Wang SY; Feng R; Lu Y; Bowman L; Ding M J Agric Food Chem; 2005 May; 53(10):4187-93. PubMed ID: 15884858 [TBL] [Abstract][Full Text] [Related]
9. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells. Assar EA; Vidalle MC; Chopra M; Hafizi S Tumour Biol; 2016 Jul; 37(7):9375-85. PubMed ID: 26779636 [TBL] [Abstract][Full Text] [Related]
10. Regulation and function of IKK and IKK-related kinases. Häcker H; Karin M Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224 [TBL] [Abstract][Full Text] [Related]
11. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Shukla S; Gupta S Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A. Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha. Clifton DR; Rydkina E; Freeman RS; Sahni SK Infect Immun; 2005 Jan; 73(1):155-65. PubMed ID: 15618150 [TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421 [TBL] [Abstract][Full Text] [Related]
15. Sulforaphane inhibits phorbol ester-stimulated IKK-NF-κB signaling and COX-2 expression in human mammary epithelial cells by targeting NF-κB activating kinase and ERK. Kim HN; Kim DH; Kim EH; Lee MH; Kundu JK; Na HK; Cha YN; Surh YJ Cancer Lett; 2014 Aug; 351(1):41-9. PubMed ID: 24747121 [TBL] [Abstract][Full Text] [Related]
16. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Dong Z; Crawford HC; Lavrovsky V; Taub D; Watts R; Matrisian LM; Colburn NH Mol Carcinog; 1997 Jul; 19(3):204-12. PubMed ID: 9254887 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor. Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309 [TBL] [Abstract][Full Text] [Related]
18. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer. Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945 [TBL] [Abstract][Full Text] [Related]
19. NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug. Caporali S; Levati L; Graziani G; Muzi A; Atzori MG; Bonmassar E; Palmieri G; Ascierto PA; D'Atri S J Transl Med; 2012 Dec; 10():252. PubMed ID: 23259744 [TBL] [Abstract][Full Text] [Related]
20. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]